Pharmacological and interventional treatment of benign prostatic obstruction: An evidence‐based comparative review

Author:

Malde Sachin1ORCID,Lam Wayne2ORCID,Adwin Zainal3ORCID,Hashim Hashim4

Affiliation:

1. Department of Urology Guy’s and St Thomas’ NHS Foundation Trust London UK

2. Division of Urology Department of Surgery LKS Faculty of Medicine Queen Mary Hospital The University of Hong Kong Hong Kong Hong Kong SAR

3. Department of Surgery Faculty of Medicine Universiti Teknologi MARA Selangor Malaysia

4. Bristol Urological Institute Southmead Hospital North Bristol NHS Trust Bristol UK

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Reference174 articles.

1. GravasSCJ GacciM GratzkeC HerrmannTRW MamoulakisC RiekenM SpeakmanMJ TikkinenKAO. Members of the EAU Non‐neurogenic male LUTS guidelines panel. EAU Guidelines on non‐neurogenic male LUTS. [cited 2019 Aug 01]. Available fromhttps://uroweb.org/guideline/treatment‐of‐non‐neurogenic‐male‐luts/

2. Long‐term consequences of medical therapy for benign prostatic hyperplasia;Bortnick EM;Rev Urol,2019

3. What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?

4. The Present Role of Alpha-Adrenergic Blockers in the Treatment of Benign Prostatic Hypertrophy

5. Silodosin in the treatment of benign prostatic hyperplasia;Rossi M;Drug Des Devel Ther,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3